Perfromance Wealth Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.52M | Sell |
|
|||||
|
2025
Q2 | $1.95M | Sell |
|
|||||
|
2025
Q1 | $2.25M | Buy |
|
|||||
|
2024
Q4 | $2.75M | Sell |
|
|||||
|
2024
Q3 | $18.9M | Buy |
|
|||||
|
2024
Q2 | $21.5M | Buy |
|
|||||
|
2024
Q1 | $8.18M | Buy |
|
|||||
|
2023
Q4 | $5.23M | Buy |
|
|||||
|
2023
Q3 | $3.7M | Buy |
|
|||||
|
2023
Q2 | $3.22M | Buy |
|
|||||
|
2023
Q1 | $3M | Buy |
|
|||||
|
2022
Q4 | $2.54M | Buy |
|
|||||
|
2022
Q3 | $1.74M | Buy |
|
|||||
|
2022
Q2 | $1.77M | Buy |
|
|||||
|
2022
Q1 | $1.67M | Buy |
|
|||||
|
2021
Q4 | $1.54M | Buy |
|